Literature DB >> 11970907

Selective p38 activation in human non-small cell lung cancer.

Alissa K Greenberg1, Sharmila Basu, Jing Hu, Ting-an Yie, Kam Meng Tchou-Wong, William N Rom, Theodore C Lee.   

Abstract

The mitogen-activated protein kinase (MAPK) pathways transmit signals from the cell membrane to the nucleus. Activation of MAPK cascades may play a role in malignant transformation. We hypothesized that enhanced expression of one or more of these pathways would occur in human lung cancers. Using Western blot analysis of tissue homogenates from resected non- small cell lung cancers and matched non-neoplastic lung tissue, we determined that only activated p38 was consistently increased in tumor compared with normal tissue. In vitro kinase assays confirmed that the levels of activated MAPK correlated with the activity of the enzymes, and immunohistochemical analysis confirmed the cellular localization of the activated MAPKs. We incubated a lung cancer cell line in a hypoxic chamber to simulate the hypoxic environment in solid lung tumors, but found no increase in p38 activation. Contrary to our expectations, ERK and JNK, the MAPK pathways traditionally associated with cell growth and perhaps malignant transformation, were not consistently activated in the human lung tumor samples. However, p38, a MAPK usually associated with stress responses, growth arrest, and apoptosis, was activated in all of the human lung cancer samples, suggesting an additional role for this pathway in malignant cell growth or transformation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11970907     DOI: 10.1165/ajrcmb.26.5.4689

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  66 in total

1.  The status of phosphorylated p38 in esophageal squamous cell carcinoma.

Authors:  Shu-Tao Zheng; Chuan-Shan Zhang; Xu Qin; Yue-Hua Gen; Tao Liu; Ilyar Sheyhidin; Xiao-Mei Lu
Journal:  Mol Biol Rep       Date:  2011-12-14       Impact factor: 2.316

Review 2.  Lung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor.

Authors:  Tzipora Goldkorn; Simone Filosto; Samuel Chung
Journal:  Antioxid Redox Signal       Date:  2014-07-01       Impact factor: 8.401

3.  Interrogating signaling nodes involved in cellular transformations using kinase activity probes.

Authors:  Cliff I Stains; Nathan C Tedford; Traci C Walkup; Elvedin Luković; Brenda N Goguen; Linda G Griffith; Douglas A Lauffenburger; Barbara Imperiali
Journal:  Chem Biol       Date:  2012-02-24

Review 4.  IFNs-signaling effects on lung cancer: an up-to-date pathways-specific review.

Authors:  Vasiliki Galani; Michalis Kastamoulas; Anna Varouktsi; Evangeli Lampri; Antigoni Mitselou; Dimitrios L Arvanitis
Journal:  Clin Exp Med       Date:  2016-07-14       Impact factor: 3.984

5.  A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis.

Authors:  Kantima Leelahavanichkul; Panomwat Amornphimoltham; Alfredo A Molinolo; John R Basile; Sittichai Koontongkaew; J Silvio Gutkind
Journal:  Mol Oncol       Date:  2013-10-12       Impact factor: 6.603

6.  p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion.

Authors:  Bangxing Hong; Haiyan Li; Mingjun Zhang; Jingda Xu; Yong Lu; Yuhuan Zheng; Jianfei Qian; Jeffrey T Chang; Jing Yang; Qing Yi
Journal:  Int J Cancer       Date:  2014-05-16       Impact factor: 7.396

7.  The investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imaging.

Authors:  Cheng-Jeng Tai; Alexander Th Wu; Jeng-Feng Chiou; Hsun-Jin Jan; Hon-Jian Wei; Chung-Huei Hsu; Che-Tong Lin; Wen-Ta Chiu; Cheng-Wen Wu; Horng-Mo Lee; Win-Ping Deng
Journal:  BMC Cancer       Date:  2010-03-12       Impact factor: 4.430

Review 8.  Signal integration by JNK and p38 MAPK pathways in cancer development.

Authors:  Erwin F Wagner; Angel R Nebreda
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

9.  Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements.

Authors:  T Rozovskaia; O Ravid-Amir; S Tillib; G Getz; E Feinstein; H Agrawal; A Nagler; E F Rappaport; I Issaeva; Y Matsuo; U R Kees; T Lapidot; F Lo Coco; R Foa; A Mazo; T Nakamura; C M Croce; G Cimino; E Domany; E Canaani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-02       Impact factor: 11.205

10.  p38 MAP kinase inhibition promotes primary tumour growth via VEGF independent mechanism.

Authors:  Adrian W O'Sullivan; Jiang H Wang; Henry P Redmond
Journal:  World J Surg Oncol       Date:  2009-11-15       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.